Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02166463 |
|---|---|
| Brief Title: | Brentuximab Vedotin and Combination Chemotherapy in Treating Children and Young Adults With Stage IIB, Stage IIIB, IVA, or IVB Hodgkin Lymphoma |
| First Submitted : | June 16, 2014 |
| First Submitted that Met QC Criteria : | June 16, 2014 |
| First Posted : | June 18, 2014 (Estimate) |
| Results First Submitted : | February 14, 2023 |
| Results First Submitted that Met QC Criteria : | May 5, 2023 |
| Results First Posted : | May 31, 2023 |
| Last Update Submitted that Met QC Criteria : | December 1, 2023 |
| Last Update Posted : | December 21, 2023 |